Multiple Sclerosis

A Guide to Pharmacologic Treatment

Daniel Ontaneda

Pubblication date October 2013
Language
Format 12 × 17 cm
Number pages 150
ISBN 978-88-9741-947-1
ISBN e-book 978-88-9741-948-8 Acquista ebook

The arena of multiple sclerosis (MS) treatment has changed substantially over the past 20 years. Now nine different agents are approved for use in MS with several different routes of administration, safety characteristics and efficacy profiles.
For the clinician and patient the availability of agents means greater flexibility and chances of disease control. However the expansion of options has also made the treatment of MS an increasingly complex field.
This book is intended to help the general neurologist, internist and pharmaceutical industry agent to quickly become familiar with the current and future options for treating relapsing forms of MS.

Target

Internists, neurologists, personnel of pharmaceutical industry.

15,00

Daniel Ontaneda

COD: 978-88-9741-947-1 Categoria:

The arena of multiple sclerosis (MS) treatment has changed substantially over the past 20 years. Now nine different agents are approved for use in MS with several different routes of administration, safety characteristics and efficacy profiles.
For the clinician and patient the availability of agents means greater flexibility and chances of disease control. However the expansion of options has also made the treatment of MS an increasingly complex field.
This book is intended to help the general neurologist, internist and pharmaceutical industry agent to quickly become familiar with the current and future options for treating relapsing forms of MS.

A Guide to Pharmacologic Treatment

Daniel Ontaneda

Pubblication date October 2013
Language
Format 12 × 17 cm
Number pages 150
ISBN 978-88-9741-947-1
ISBN e-book 978-88-9741-948-8 Acquista ebook

Authors

Daniel Ontaneda
Assistant Professor of Medicine and Neurology, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Ohio, USA

Summary

Introduction

  • Scope
  • Overview of multiple sclerosis

Disease modifying agents for multiple sclerosis

  • Interferon for MS
  • Glatiramer acetate for MS
  • Mitoxantrone for MS
  • Natalizumab for MS
  • Fingolimod for MS
  • Teriflunomide for MS
  • Dimethyl fumarate for MS

Treatment of relapses

  • Defining relapses
  • Treatment of MS relapses

Emerging therapies for multiple sclerosis

  • Laquinimod for MS
  • Alemtuzumab for MS
  • Daclizumab for MS
  • Ocrelizumab and rituximab for MS

Ti potrebbe interessare…